Get the Stockscreener App
7.11
3.27%
-0.24
Pre-market:
7.81
0.70
+9.85%
Quanterix Corp stock is traded at $7.11, with a volume of 438.01K.
It is down -3.27% in the last 24 hours and down -11.79% over the past month.
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.
See More
Previous Close:
$7.35
Open:
$7.29
24h Volume:
438.01K
Relative Volume:
0.64
Market Cap:
$352.58M
Revenue:
$121.14M
Net Income/Loss:
$-32.33M
P/E Ratio:
-8.2674
EPS:
-0.86
Net Cash Flow:
$-22.69M
1W Performance:
-5.07%
1M Performance:
-11.79%
6M Performance:
-44.54%
1Y Performance:
-72.98%
1-Day Range:
$7.08
$7.385
1-Week Range:
$7.08
$7.82
52-Week Range:
$7.08
$27.37
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
7.11 | 352.58M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
Quanterix Corp (NASDAQ: QTRX) Is Down -1.62% – Is It Capable Of A Rally? - Stocks Register
Rhumbline Advisers Lowers Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
Quanterix Corp [NASDAQ: QTRX] Sees Decrease in Stock Value - Knox Daily
Quanterix stock plunges to 52-week low of $7.3 amid market challenges - Investing.com
Can Quanterix's Akoya Acquisition Transform Biomarker Detection and Deliver $1B Revenue? - StockTitan
Quanterix (QTRX) Projected to Post Quarterly Earnings on Thursday - Defense World
Quanterix advances towards Akoya Biosciences acquisition By Investing.com - Investing.com Australia
Akoya Biosciences’ Merger with Quanterix Moves Forward - Investing.com India
Akoya Biosciences' Merger with Quanterix Moves Forward - Investing.com
Quanterix advances towards Akoya Biosciences acquisition - Investing.com
Quanterix stock plunges to 52-week low at $7.47 amid market challenges - Investing.com
Akoya climbs after merger deal with Quanterix - MSN
Kent Lake opposes Quanterix-Akoya merger, citing undervaluation - Investing.com
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerEVGR, QTRX, RKDA, EBTC - Marketscreener.com
Bullish Quanterix Insiders Loaded Up On US$831.7k Of Stock - Yahoo Finance
Understanding the Risks of Investing in Quanterix Corp (QTRX) - Knox Daily
Daily Progress: Quanterix Corp (QTRX) Drop -3.57, Closing at 7.83 - The Dwinnex
Quanterix Co. (NASDAQ:QTRX) Shares Purchased by abrdn plc - MarketBeat
Should You Expect Quanterix Corp (NASDAQ:QTRX) To Recover From Its -1.11% Drop From Highs? - Marketing Sentinel
The growth track for Quanterix Corp (QTRX) has changed recently - SETE News
AllianceBernstein L.P. Reduces Stake in Quanterix Corp - GuruFocus.com
Quanterix Corp Inc. (QTRX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Examining the Potential Price Growth of Quanterix Corp (QTRX) - Knox Daily
Trading Day Review: Quanterix Corp (QTRX) Loses Momentum, Closing at 8.83 - The Dwinnex
Quanterix sets 2025 executive incentive plan - MSN
Quanterix sets 2025 executive incentive plan By Investing.com - Investing.com Australia
2025-01-28 | QTRX Investor News: Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action InvestigationQTRX | NDAQ:QTRX | Press Release - Stockhouse Publishing
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix CorporationQTRX - PR Newswire
Quanterix Nears All-Stock Deal for Akoya Biosciences - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Quanterix Corporation (QTRX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Leerink Partnrs Lowers Earnings Estimates for Quanterix - Defense World
Leerink Partnrs Predicts Weaker Earnings for Quanterix - MarketBeat
JPMorgan Chase & Co. Acquires 47,873 Shares of Quanterix Co. (NASDAQ:QTRX) - Defense World
2025-01-18 | QTRX Investor News: Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action InvestigationQTRX | NDAQ:QTRX | Press Release - Stockhouse Publishing
Quanterix stock reaffirms Buy rating, price target on mixed results By Investing.com - Investing.com South Africa
Quanterix stock reaffirms Buy rating, price target on mixed results - Investing.com
Quanterix reports steady growth amid challenging market By Investing.com - Investing.com Australia
Quanterix reports steady growth amid challenging market - Investing.com
Quanterix Achieves 12% Revenue Growth in 2024, Marks Seventh Quarter of Double-Digit Growth - StockTitan
Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action InvestigationQTRX - PR Newswire
Quanterix merging with Akoya to bolster biomarker portfolio - BioWorld Online
Quanterix announces acquisition of Akoya Biosciences - Investing.com
Quanterix Prepares to Accelerate Market Development with First Integrated Solution for Ultra-Sensitive Detection of Biomarkers - Defense World
Billerica diagnostics maker Quanterix to acquire Marlborough biotech - The Business Journals
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quanterix Corp Stock (QTRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Toloue Masoud | President & CEO |
Aug 13 '24 |
Buy |
10.90 |
19,000 |
207,100 |
354,119 |
| OLSON LAURIE J | Director |
May 14 '24 |
Sale |
16.98 |
1,500 |
25,470 |
13,738 |
| OLSON LAURIE J | Director |
Apr 01 '24 |
Option Exercise |
12.86 |
1,000 |
12,860 |
16,238 |
| OLSON LAURIE J | Director |
Apr 01 '24 |
Sale |
23.50 |
1,000 |
23,500 |
15,238 |
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):